000 04334nam a2200397 i 4500
999 _c100446
_d100446
_x1
001 100446
003 ES-MaUEC
005 20230102112956.0
006 a||||fo|||| 00| 0
007 cr nn 008mamaa
008 170929s2018 gw | fo |||| 0|eng d
020 _a9783662544693
024 7 _a10.1007/978-3-662-54469-3
_2doi
040 _aES-MaUEC
_bspa
_cES-MaUEC
_dES-MaUEC
041 0 _aeng
050 4 _aRD686
_b2018 EB
245 0 _aManagement of Periprosthetic Joint Infection :
_bA global perspective on diagnosis, treatment options, prevention strategies and their economic impact
_cedited by Klaus-Dieter Kühn
264 1 _aBerlin, Heidelberg
_bSpringer International Publishing
_c2018
300 _a1 recurso en línea (XVIII, 366 páginas)
_b196 ilustraciones a color
336 _2rdacontent
_aTexto
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _atext file
_bPDF
490 0 _aMedicine (Springer-11650)
505 0 _aFrom the contents: 1. Introduction -- 2. Economic -- 3. Clinical Aspects -- 4. Diagnosis -- 5. Prevention -- 6. Treatment -- 7. ALBC -- 8. Spacer -- 9. Coating.
520 3 _aPeriprosthetic joint infection (PJI) is among the most serious complications in the field of endoprosthetics. The number of PJIs is increasing worldwide and poses a real interdisciplinary challenge for everyone involved. For the patient concerned, it is necessary to promptly work out an adequate therapy solution to fight off the infection. Both the clinical experience of the surgeon and the proper diagnostic processes are prerequisite for the reliable detection and identification of an infection. The microbiologist is responsible for identifying the causative germs by screening the patient's synovial fluid and tissue samples. Based on the findings and subsequent resistance testing, the infectious disease specialist can recommend the appropriate antibiotic therapy. Furthermore, the clinical pharmacist is consulted regularly throughout the therapy to discuss the risk of potential drug interactions. The surgeon will proceed with the revision surgery, following defined algorithms. Adequate radical debridement of infected and necrotic surrounding tissue is the most important step towards a successful cure of the infection. Accompanying the surgery, anti-infective agents are given systemically and locally. While systemic application of anti-infectives mainly reduces the number of haematogenic-spreading planktonic germs, local application immediately forms a colonization barrier and protects the implant from sessile biofilm formation. Concurrently, antibiotics are actively released from the implant, resulting in local germ reduction. Thus, local agents are embedded in the concept of surgical PJI treatment as a reliable adjuvant measure and they sustainably support the successful outcome. In one-stage procedures, local agents are released from specialized antibiotic-loaded bone cements, while in two- or multi-stage procedures, local agents are released from corresponding temporary spacers (interim prostheses). Even from an economic standpoint, the combination of systemic and local agent application is meaningful. Furthermore, there are some interesting trends towards the coating of metallic implants to protect against biofilm formation on the implant surface. On the basis of their personal experience, specialists from all over the world present, explain and discuss preventive approaches, appropriate diagnostic strategies for detection, reproducible effective surgical treatments  as well as the economic impact of PJI. The reader can use this book as a solid platform for comparing their own approach to PJI treatment with the specialists' recommendations.  .
988 _aSpringer_Medicine_2018
650 7 _2embne
_9191993
_aArticulaciones
_xPrótesis
650 7 _2embne
_9269140
_aArticulaciones
_xInfecciones
700 1 _aKühn, Klaus-Dieter.
_eeditor literario
776 0 8 _iEdición impresa:
_z9783662544686
776 0 8 _iEdición impresa:
_z9783662544709
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-662-54469-3
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
_n0
998 _b04/2020
_dz
_eb
_zSI